Evotec SE (EVO) - 5i Research

Evotec SE (EVO $4.26)
- $4.26 Cap: $377M
- View EVO Profile
- View Questions on EVO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Sernova Biotherapeutics Inc. (SVA $0.17)
- $0.17 Cap: $55M
- View SVA Profile
- View Questions on SVA
Evotec SE (EVO $4.26)
- $4.26 Cap: $377M
- View EVO Profile
- View Questions on EVO

Q: Under the "lottery ticket" portion of my portfolio I own SVA, they announced a deal with EVO. RBC has no information on EVO, what can you tell me about EVO, thoughts on the deal?

Read Answer Asked by Charles on May 19, 2022